Clinical Trial Update: Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial update on optimizing treatment for dry eye disease due to meibomian gland dysfunction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Meibomian Gland Dysfunction

Snippet

Sponsor: Oslo University Hospital | Conditions: Dry Eye Syndromes, Meibomian Gland Dysfunction | Phase 4 | Status: COMPLETED